戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ogy surprisingly revealed a biliary mucinous cystadenoma.
2 normal ovarian surface epithelium and benign cystadenoma.
3            Simple cysts that grow are likely cystadenomas.
4 as, endolymphatic sac tumors, and epididymal cystadenomas.
5 ignant potential and carcinomas but not with cystadenomas.
6 ents underwent surgery for 14 benign (serous cystadenomas = 10, Hamoudi = 2, lymphoepithelial = 1, si
7 denoma 9, borderline 9, cancer 4), 23 serous cystadenomas, 13 other pancreatic cysts, 27 pancreatic e
8              Of the 19 patients with biliary cystadenoma, 16 (84.2 %) were female.
9 oup were IPMN without invasive cancer (30%), cystadenoma (17%), and pancreatic ductal adenocarcinoma
10 hronic pancreatitis (24%), benign pancreatic cystadenoma (22%), pancreatic adenocarcinoma (18%), neur
11 lasms of the pancreas, 54 were classified as cystadenomas, 23 as noninvasive proliferative cystic muc
12 y 100% incidence of multiple bilateral renal cystadenomas, 50% incidence of liver hemangiomas, and 32
13 pseudopapillary neoplasms(12%), and mucinous cystadenomas (6%).
14                                      Biliary cystadenoma, a benign hepatic tumor arising from Von Mey
15 ncy and the development of pancreatic serous cystadenomas, a tumor type associated with PJS.
16  of BRAF and KRAS occur in the epithelium of cystadenomas adjacent to SBTs and strongly suggest that
17            Tsc1 heterozygotes develop kidney cystadenomas and liver hemangiomas at high frequency, bu
18                  Other cysts, such as serous cystadenomas and pancreatic fluid collections, do not ha
19 ovarian cancers compared with benign ovarian cystadenomas and that gankyrin regulates FSH upregulatio
20 seven were confirmed benign at surgery (four cystadenomas and three inflammatory), one had a benign p
21  Nineteen patients with intrahepatic biliary cystadenomas and two patients with biliary cystadenocarc
22 ovaries: There was one dermoid, one mucinous cystadenoma, and two adenofibromas.
23 d in both the cell lines and Tsc mouse renal cystadenomas, and ectopic expression of PDGFRbeta in Tsc
24                                  Paraovarian cystadenomas are cystic masses that usually contain one
25                         Large (>4 cm) serous cystadenomas are more likely to be symptomatic.
26 h many cysts, such as pseudocysts and serous cystadenomas, are benign and can be monitored clinically
27  the first documentation of a DALM (mucinous cystadenoma) arising in the appendix in the setting of U
28                                      Biliary cystadenoma (BCA) and biliary cystadenocarcinoma (BCAC)
29 re we show that a subset of cultured ovarian cystadenoma cells expressing SV40 large T-antigen, which
30 d to a lesser extent VEGF-A levels, in renal cystadenoma cells in a Tsc2+/- mouse model.
31 alized ovarian surface epithelia and ovarian cystadenoma cells showed much higher similarity to prima
32  a subset of SV40 large T-antigen-expressing cystadenoma cells.
33 ancers, ovarian surface epithelia cells, and cystadenoma cells.
34  and two of four neoplasms (50%) (all serous cystadenomas) demonstrated T2 dark spots.
35                                    The renal cystadenomas develop from intercalated cells of the cort
36 detected in SBTs were also identified in the cystadenoma epithelium adjacent to the SBTs in six (86%)
37                     As compared to SBTs, the cystadenoma epithelium, like ovarian surface epithelium,
38 es of histopathologically proved paraovarian cystadenomas from January 1993 through December 1996 in
39 y genetic background, with fewer large renal cystadenomas in the outbred Black Swiss background and m
40 atients had pathologically confirmed biliary cystadenomas, including one with a biliary cystadenocarc
41  multifocal colon cancer, and an appendiceal cystadenoma is described.
42 lecular genetic studies suggest that ovarian cystadenomas, low malignant potential tumors, and carcin
43              Among O-glycans from an ovarian cystadenoma mucin, isomeric oligosaccharide sequences, s
44                                      Biliary cystadenoma must be recognized and treated differently t
45  = 21; 3%), cystadenocarcinoma (n = 14; 2%), cystadenoma (n = 25; 4%), and other (n = 45; 7%).
46         Chronic pancreatitis (n = 7), serous cystadenomas (n = 5), benign mucinous cystic neoplasms (
47  papillary mucinous neoplasms (n=15), serous cystadenomas (n=12), or pseudocysts (n=9), with confirma
48      Neoplasms were reclassified as mucinous cystadenomas, noninvasive proliferative mucinous cystic
49 total of 106 patients presenting with serous cystadenoma of the pancreas from 1976-2004 were identifi
50 ine whether surgical enucleation of mucinous cystadenoma of the pancreas is a safe and adequate opera
51                                       Serous cystadenoma of the pancreas is the most common benign pa
52 mas, endolymphatic-sac tumors, and papillary cystadenomas of the epididymis and broad ligament.
53                                     Mucinous cystadenomas of the pancreas are premalignant cystic les
54 rience suggests that enucleation of mucinous cystadenomas of the pancreas can be performed safely and
55 ween January 1990 and June 1997, 36 mucinous cystadenomas of the pancreas were resected at The Johns
56 ine tumors and cysts, pheochromocytomas, and cystadenomas of the reproductive adnexal organs.
57 reviewed to confirm the diagnosis of biliary cystadenoma or biliary cystadenocarcinoma by 2 GI pathol
58 s with IPMN, but not in patients with serous cystadenoma or controls.
59  findings of surgically excised lesions were cystadenoma or cystadenofibroma (n = 14; 11 serous, thre
60                         Fourteen paraovarian cystadenomas or cystadenofibromas were identified in 14
61 ity alterations were 71% and 100% for serous cystadenomas (PPV, 100%; NPV, 98%), and 68% and 98% for
62 eoplasms) from benign cystic lesions (serous cystadenomas+pseudocysts) with a 78% sensitivity at 80%
63 ors, we recommend resection for large serous cystadenomas regardless of the presence or absence of sy
64             Many patients with benign serous cystadenoma (SCA) of the pancreas will undergo resection
65 eveloped a novel pancreatic neoplasm, serous cystadenoma (SCA), presenting as large epithelial tumors
66 h of the major neoplastic cyst types: serous cystadenomas (SCAs), intraductal papillary mucinous neop
67                                   Ten serous cystadenomas served as negative controls.
68                                       Serous cystadenomas, solid and cystic papillary (Hamoudi) tumor
69 neoplasms, mucinous cystic neoplasms, serous cystadenomas, solid pseudopapillary neoplasms, cystic va
70 be distinguished from serous lesions (serous cystadenomas) that are nearly always benign.
71 n both SBTs and the adjacent epithelium from cystadenomas, the presumed precursor of SBTs.
72 ation about the imaging findings for biliary cystadenoma to reduce the demonstrated delay in appropri
73  Renal lesions progressed from cysts through cystadenomas to solid carcinomas.
74  result, management for patients with serous cystadenomas varies widely in current practice.
75  are potentially malignant and that mucinous cystadenomas, when completely removed, are biologically
76    DLX4 was not detected in normal ovary and cystadenomas, whereas its expression in ovarian carcinom
77                         On follow-up, serous cystadenomas with TP53/TERT mutations exhibited interval